ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I–III small cell lung cancer

医学 指南 放射治疗 阶段(地层学) 放射科 肺癌 肿瘤科 医学物理学 小细胞肺癌 肿瘤分期 内科学 癌症 无线电技术
作者
Antonin Levy,Cecile Le Pechoux,Bjørn Henning Grønberg,Andreas Rimner,Fabio Y. Moraes,Valeria Dionisi,Jessica Menis,Pedro Rocha,Noemi Reguart,Coen Hurkmans,Sara Ramella,B. Slotman,Corinne Faivre-Finn
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:219: 111516-111516 被引量:1
标识
DOI:10.1016/j.radonc.2026.111516
摘要

INTRODUCTION: Stage I-III limited-stage small cell lung cancer (SCLC) is a highly aggressive yet potentially curable disease with concurrent chemoradiotherapy. Thoracic radiation therapy (RT) plays a central role in the management of stage I-III SCLC; however significant variation exists in staging, target volume delineation, dose prescription, and integration with systemic therapy. This document provides an updated European recommendations on the use of RT in stage I-III SCLC, reflecting recent evidence and advancements in clinical practice. MATERIAL AND METHODS: A panel of European experts was convened under the auspices of the ESTRO Guidelines Committee, in collaboration with EORTC Lung Cancer Group, and to review the available evidence and develop recommendations. Key topics addressed included disease staging, radiotherapy planning and delivery, and the integration with chemotherapy and immunotherapy. RESULTS: Accurate staging should include PET-CT and brain MRI. Thoracic RT should be initiated early during chemotherapy. Standard dose schedules include 45 Gy in 30 fractions (BID) or 66 Gy in 33 fractions once daily, using conformal techniques such as IMRT/VMAT, involved field nodal irradiation, respiratory motion management (e.g., 4D-CT, breath-hold) and image guidance (e.g., cone-beam CT [CBCT]). Concurrent chemotherapy with 4-6 cycles platinum-etoposide followed by consolidation durvalumab for up to two years is the standard of care in fit patients. Prophylactic cerebral irradiation (PCI) continues to represent the standard approach following treatment response; while hippocampal-sparing PCI and MRI surveillance strategies are being actively evaluated in ongoing studies. In selected cases, stereotactic body radiotherapy (SBRT) may be appropriate for medically inoperable early-stage disease without nodal involvement, and adjuvant RT can be considered for R1 resections or pN2 involvement. Emerging strategies, including adaptive RT, dose escalation and the integration of precision medicine have the potential to improve the therapeutic ratio. Integration with immunotherapy and/or novel agents, such as delta-like ligand 3 (DLL3)-targeted therapies, is under active investigation. Biomarker-guided treatment personalisation remains investigational. CONCLUSIONS: These updated European guidelines provide a comprehensive framework for standardized, high-quality care in stage I-III SCLC and establish a reference standard to harmonize radiotherapy approaches and inform the design of upcoming clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wy.he的应助被车访枫采纳,获得10
刚刚
lyc完成签到,获得积分10
1秒前
HEGONG完成签到,获得积分10
2秒前
忧郁的妙梦完成签到,获得积分10
2秒前
Xue完成签到,获得积分10
2秒前
NexusExplorer的应助被柚子眲采纳,获得10
2秒前
胡玉娇完成签到,获得积分10
4秒前
4秒前
bubi完成签到,获得积分10
4秒前
简单的元珊完成签到,获得积分0
6秒前
wjl完成签到,获得积分10
6秒前
6秒前
歪歪关注了科研通微信公众号
6秒前
香香香发布了新的文献求助10
6秒前
7秒前
我是老大的应助被lxl采纳,获得10
7秒前
喜悦的秋柔完成签到,获得积分10
8秒前
明理小土豆完成签到,获得积分10
9秒前
彭于晏的应助被nicoleJ采纳,获得10
9秒前
无常完成签到,获得积分10
9秒前
HAOYUN驳回了Ava的应助
9秒前
9秒前
吃不饱发布了新的文献求助10
9秒前
9秒前
酷波er的应助被火星猎人采纳,获得10
11秒前
浅唱夏末发布了新的文献求助10
11秒前
黑米粥发布了新的文献求助200
11秒前
11秒前
FashionBoy的应助被尼克采纳,获得10
14秒前
14秒前
14秒前
Mhh发布了新的文献求助10
15秒前
15秒前
领导范儿的应助被dde采纳,获得10
15秒前
笑然发布了新的文献求助10
17秒前
982289172发布了新的文献求助10
17秒前
大宝宝完成签到 ,获得积分10
17秒前
18秒前
田様的应助被houyushen采纳,获得10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187572
求助须知:如何正确求助?哪些是违规求助? 9575676
关于积分的说明 21842241
捐赠科研通 7785368
什么是DOI,文献DOI怎么找? 3435022
关于科研通互助平台的介绍 2559428
邀请新用户注册赠送积分活动 2481917